Torben Mourits‐Andersen

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Tina Green, Ken H. Young, Carlo Visco et al. · Journal of Clinical Oncology · 2012 · 677 citations · Full text

A phase <scp>III</scp> randomized trial comparing glucocorticoid monotherapy <i>versus</i> glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia

Henrik Birgens, Henrik Frederiksen, Hans Carl Hasselbalch et al. · British Journal of Haematology · 2013 · 161 citations · Full text

Immunohematology, Immunodeficiencies, Immunology +22

Glycosylated haemoglobin (HbA_1c) in iron‐ and vitamin B12 deficiency

Paul Gram-Hansen, Jeppe Eriksen, Torben Mourits‐Andersen et al. · Journal of Internal Medicine · 1990 · 102 citations

Nutrition, Iron Metabolism, Glycobiology +17

R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group

Anne Ortved Gang, Camilla Strøm, Mette Ølgod Pedersen et al. · Annals of Oncology · 2011 · 76 citations · Full text

Hematological Malignancy, Population-based Investigation, Lymphoid Neoplasia +7

A phase II study of vorinostat (<scp>MK</scp>‐0683) in patients with polycythaemia vera and essential thrombocythaemia

Christen Lykkegaard Andersen, Mary Frances McMullin, Elisabeth Ejerblad et al. · British Journal of Haematology · 2013 · 70 citations